Medclair Invest AB reported earnings results for the fourth quarter and full year ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 10.65 million compared to SEK 4.06 million a year ago. Net income was SEK 1.07 million compared to net loss of SEK 4.22 million a year ago. Basic earnings per share from continuing operations was SEK 0.01 compared to basic loss per share from continuing operations of SEK 0.05 a year ago.
For the full year, sales was SEK 28.17 million compared to SEK 13.32 million a year ago. Net loss was SEK 5 million compared to SEK 13.02 million a year ago. Basic loss per share from continuing operations was SEK 0.06 compared to SEK 0.16 a year ago.